Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis

View ORCID ProfileHeather Marriott, View ORCID ProfileThomas P. Spargo, View ORCID ProfileAhmad Al Khleifat, View ORCID ProfileIsabella Fogh, Project MinE ALS Sequencing Consortium, Peter M Andersen, Nazli A. Başak, View ORCID ProfileJohnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, View ORCID ProfileMamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, View ORCID ProfileVincenzo Silani, Nicola Ticozzi, View ORCID ProfilePhilip van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, View ORCID ProfileJan H. Veldink, Richard J. Dobson, Patrick Schwab, View ORCID ProfileAmmar Al-Chalabi, Alfredo Iacoangeli
doi: https://doi.org/10.1101/2022.11.03.22281905
Heather Marriott
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heather Marriott
Thomas P. Spargo
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas P. Spargo
Ahmad Al Khleifat
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmad Al Khleifat
Isabella Fogh
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Isabella Fogh
Peter M Andersen
3Department of Clinical Science, Umeå University, Umeå SE-901 85, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nazli A. Başak
4Koc University, School of Medicine, Translational Medicine Research Center, NDAL, Istanbul, 34450, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johnathan Cooper-Knock
5Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johnathan Cooper-Knock
Philippe Corcia
6UMR 1253, Université de Tours, Inserm, Tours 37044, France
7Centre de référence sur la SLA, CHU de Tours, Tours 37044, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Couratier
8Centre de référence sur la SLA, CHRU de Limoges, Limoges, France
9UMR 1094, Université de Limoges, Inserm, Limoges 87025, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mamede de Carvalho
10Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mamede de Carvalho
Vivian Drory
11Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv 64239, Israel
12Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan D. Glass
13Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, GA 30322, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Gotkine
14Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91904, Israel
15Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Jerusalem 91120, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orla Hardiman
16Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John E. Landers
17Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell McLaughlin
18Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesús S. Mora Pardina
19ALS Unit, Hospital San Rafael, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen E. Morrison
20School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7BL, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susana Pinto
10Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Povedano
21Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona 08907, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher E. Shaw
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela J. Shaw
5Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield S10 2HQ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincenzo Silani
22Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
23Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincenzo Silani
Nicola Ticozzi
22Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan 20149, Italy
23Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan 20122
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip van Damme
24University Hospitals Leuven, Department of Neurology, Leuven 3000, Belgium
25VIB, Center for Brain and Disease Research, Leuven, Belgium & Neuroscience Department, Leuven Brain Institute, KU Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philip van Damme
Leonard H. van den Berg
26Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Vourc’h
6UMR 1253, Université de Tours, Inserm, Tours 37044, France
27Service de Biochimie et Biologie molécularie, CHU de Tours, Tours 37044, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Weber
28Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan H. Veldink
26Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht 3584 CX, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan H. Veldink
Richard J. Dobson
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
29NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, UK
30Institute of Health Informatics, University College London, London, NW1 2DA, UK
31NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Schwab
32GlaxoSmithKline, Artificial Intelligence and Machine Learning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ammar Al-Chalabi
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
33King’s College Hospital, London, SE5 9RS, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ammar Al-Chalabi
Alfredo Iacoangeli
1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF, UK
2Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, SE5 8AF UK
29NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alfredo.iacoangeli@kcl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective Genetic variation in the neurofilament heavy chain gene (NEFH) has been convincingly linked to the pathogenesis of multiple neurodegenerative diseases, however, the relationship between NEFH mutations and ALS susceptibility has not been robustly explored. We therefore wanted to determine if genetic variants in NEFH modify ALS risk.

Methods We performed fixed and random effects model meta-analysis of published case-control studies reporting NEFH variant frequencies using next-generation sequencing, microarray or PCR-based approaches. Comprehensive screening and rare variant burden analysis of NEFH variation in the Project MinE ALS whole-genome sequencing data set was also conducted.

Results We identified 12 case-control studies that reported NEFH variant frequencies, for a total of 9,496 samples (4,527 ALS cases and 4,969 controls). Fixed effects meta-analysis found that rare (MAF<1%) missense variants in the tail domain of NEFH increase ALS risk (OR 4.56, 95% CI 2.13-9.72, p<0.0001). A total of 591 rare NEFH variants, mostly novel (78.2%), were found in the Project MinE dataset (8,903 samples: 6,469 cases and 2,434 controls). Burden analysis showed ultra-rare (MAF <0.1%) pathogenic missense variants in the tail domain are associated with ALS (OR 1.94, 95% CI 0.86-4.37, Madsen-Browning p=0.039), replicating and confirming the meta-analysis finding. High-frequency rare (MAF 0.1-1%) tail in-frame deletions also confer susceptibility to ALS (OR 1.18, 95% CI 0.67-2.07, SKAT-O p=0.03), which supports previous findings.

Interpretation This study shows that NEFH tail domain variants are a risk factor of ALS and supports the inclusion of missense and in-frame deletion NEFH variants in ALS genetic screening panels.

Competing Interest Statement

JHV reports to have sponsored research agreements with Biogen and Astra Zeneca. AAC reports consultancies or advisory boards for Amylyx, Apellis, Biogen, Brainstorm, Cytokinetics, GenieUs, GSK, Lilly, Mitsubishi Tanabe Pharma, Novartis, OrionPharma, Quralis, Sano, Sanofi, and Wave Pharmaceuticals. The other authors have nothing to report.

Funding Statement

The authors are supported by South London and Maudsley NHS Foundation Trust; MND Scotland; Motor Neurone Disease Association; National Institute for Health Research; Darby Rimmer MND Foundation; Spastic Paraplegia Foundation and Rosetrees Trust. HM is supported by GlaxoSmithKline and the KCL funded centre for Doctoral Training (CDT) in Data-Driven Health. AAK is funded by ALS Association Milton Safenowitz Research Fellowship (grant number22-PDF-609.DOI :10.52546/pc.gr.150909.), The Motor Neurone Disease Association (MNDA) Fellowship (Al Khleifat/Oct21/975-799), The Darby Rimmer Foundation, and The NIHR Maudsley Biomedical Research Centre. AI is funded by the Motor Neurone Disease Association and The NIHR Maudsley Biomedical Research Centre. AAC is an NIHR Senior Investigator (NIHR202421) and has received support from an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The work is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu (United Kingdom, Medical Research Council (MR/L501529/1; MR/R024804/1) and Economic and Social Research Council (ES/L008238/1)) and through the Motor Neurone Disease Association, My Name'5 Doddie Foundation, and Alan Davidson Foundation. This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. Project MinE Belgium was supported by a grant from IWT (no 140935), the ALS Liga België, the National Lottery of Belgium and the KU Leuven Opening the Future Fund. PVD holds a senior clinical investigatorship of FWO-Vlaanderen (G077121N) and is supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the ALS Liga België; and the KU Leuven funds "Een Hart voor ALS", "Laeversfonds voor ALS Onderzoek" and the "Valéry Perrier Race against ALS Fund".

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Genetic data generated from these cohorts can be downloaded upon request from the Project MinE Data Browser (http://databrowser.projectmine.com).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis
Heather Marriott, Thomas P. Spargo, Ahmad Al Khleifat, Isabella Fogh, Project MinE ALS Sequencing Consortium, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Richard J. Dobson, Patrick Schwab, Ammar Al-Chalabi, Alfredo Iacoangeli
medRxiv 2022.11.03.22281905; doi: https://doi.org/10.1101/2022.11.03.22281905
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis
Heather Marriott, Thomas P. Spargo, Ahmad Al Khleifat, Isabella Fogh, Project MinE ALS Sequencing Consortium, Peter M Andersen, Nazli A. Başak, Johnathan Cooper-Knock, Philippe Corcia, Philippe Couratier, Mamede de Carvalho, Vivian Drory, Jonathan D. Glass, Marc Gotkine, Orla Hardiman, John E. Landers, Russell McLaughlin, Jesús S. Mora Pardina, Karen E. Morrison, Susana Pinto, Monica Povedano, Christopher E. Shaw, Pamela J. Shaw, Vincenzo Silani, Nicola Ticozzi, Philip van Damme, Leonard H. van den Berg, Patrick Vourc’h, Markus Weber, Jan H. Veldink, Richard J. Dobson, Patrick Schwab, Ammar Al-Chalabi, Alfredo Iacoangeli
medRxiv 2022.11.03.22281905; doi: https://doi.org/10.1101/2022.11.03.22281905

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10021)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4833)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)